Culture, Society & Lifestyle Press Releases

Published on October 4, 2024 - 14:31 GMT

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2024 - 14:00 GMT

Power Solutions International to attend The Battery Show in Detroit, October 7-10

WOOD DALE, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (PSI) (OTC Pink: PSIX), a global leader in the design, engineering, and manufacture of advanced, emission-certified engines and power systems, is excited to announce its …

Distribution channels: Automotive Industry, Culture, Society & Lifestyle ...

Published on October 4, 2024 - 13:30 GMT

Polysleep CEO Jeremiah Curvers Unveils New Podcast Season and Launches ‘Up At Night’ for Personal Development Enthusiasts

MONTREAL, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Polysleep Studio is excited to announce the return of "Wake Up Call," hosted by Co-Founder and CEO Jeremiah Curvers, alongside the launch of his new podcast, "Up At Night." "Wake Up Call…

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on October 4, 2024 - 13:18 GMT

NMFTA Cybersecurity Conference Keynote Speaker Announced: White House’s Office of the National Cyber Director’s Stephen Viña

ALEXANDRIA, Va., Oct. 04, 2024 (GLOBE NEWSWIRE) -- The National Motor Freight Traffic Association, Inc. (NMFTA)™ is pleased to announce that Stephen Viña, with the White House’s Office of the National Cyber Director, will be the keynote speaker for this …

Distribution channels:

Published on October 4, 2024 - 13:10 GMT

MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024

NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2024 - 01:09 GMT

National Nonprofit, City Thread, to Advance 20+ U.S. Cities’ Transportation Infrastructure Goals

City Thread is accepting applications for its AMP Grant program - to help up to 4 cities in the U.S. achieve their transportation infrastructure goals faster. DENVER, CO, UNITED STATES, October 3, 2024 /⁨EINPresswire.com⁩/ -- City Thread, a national …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on October 4, 2024 - 13:07 GMT

Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumors Preclinical data on MDNA113, Medicenna's first-in-class, masked, tumor-targeted bifunctional anti-PD1-IL-2 Superkine, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2024 - 13:05 GMT

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting

WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on October 4, 2024 - 13:05 GMT

BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

SAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2024 - 13:05 GMT

Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its abstract on …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on October 4, 2024 - 13:05 GMT

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting

BELTSVILLE, Md., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced two …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on October 4, 2024 - 13:05 GMT

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced an upcoming …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2024 - 13:05 GMT

Umoja Biopharma Announces Poster Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and autoimmunity, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...